Raltegravir 400mg Tablet
Description:
Raltegravir 400mg Tablet is an antiretroviral medication belonging to the class of HIV integrase strand transfer inhibitors (INSTIs). It is used in the treatment of HIV-1 infection in combination with other antiretroviral agents. Raltegravir works by blocking the action of the integrase enzyme, which is essential for the integration of viral DNA into the host cell genome—a critical step in the HIV replication cycle.
Therapeutic Use:
Treatment of HIV-1 infection in adults and pediatric patients
Used as part of combination antiretroviral therapy (ART) to reduce viral load and improve immune function
Mechanism of Action:
Raltegravir inhibits the HIV integrase enzyme, preventing the insertion of viral genetic material into human DNA, thereby stopping the replication of the virus within the body.
Packaging:
Available in tablet form, typically packed in blister strips or bottles. Common packaging includes 10x10 tablets (100 tablets per box) or as per client and regulatory requirements.
Note:
This medication is not a cure for HIV but significantly helps in controlling the infection when used consistently. Raltegravir should be taken under medical supervision, and routine monitoring of viral load and immune parameters is recommended during therapy.
Would you like assistance with export-ready product descriptions or branding material?
